🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
AIMS To study the effects of the decrease in iron tissue depots after sched...
Status
Completed
Location
Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)
Start Date
2015-01
Trial ID
NCT02460445
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Start Date
2023-02-01
Trial ID
NCT05662319
Islet transplantation may be appropriate in up to 10% of adults with Type 1...
Status
Terminated
Location
Royal Infirmary Edinburgh
Start Date
2016-06
Trial ID
NCT03063229
The overall aim of this research is to improve secondary stroke prevention ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07454707
Treatments Being Tested
This pilot study will evaluate the performance of the Quantra System compri...
Status
Completed
Location
Texas Tech University Health Sciences Center El Paso
Start Date
2019-03-04
Trial ID
NCT03912545
Treatments Being Tested
Blood products are commonly used before invasive procedures in patients wit...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT02362178
This novel fibrinolytic agent is a 136 amino acid single chain protein secr...
Status
Completed
Location
Sri Jayadeva Institute of Cardiology.
Start Date
2010-10
Trial ID
NCT01305226
Treatments Being Tested